DCA and CancerDCA as a Cancer Treatment - Sodium Dichloroacetate

Butyrate Increases Apoptosis Induced by Different Antineoplastic Drugs in Monocytic Leukemia Cells

M.G. Ramosa, F.L.A. Rabeloa, G. Brumattib, A.E. Bueno-da-Silvab, G.P. Amarante-Mendesb, J.I. Alvarez-Leitea
aDepartamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, and
bDepartamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de SãoPaulo, São Paulo, Brazil

Chemotherapy 2004;50:221-228 (DOI: 10.1159/000081942)


Background: Apoptosis is an essential form of cell death, the failure of which can lead to cancer development. Cancer including leukemia is usually treated with chemotherapeutic drugs that can be effective, but frequently problems are encountered that impair the success of the treatment. Butyrate is a short-chain fatty acid that can have many effects on different cells, including apoptosis. Methods: The effect of a combination treatment with butyrate and antineoplastic agents Ara-C, etoposide and vincristine is evaluate on the leukemic cell line THP-1.

Results: We show that butyrate increased apoptosis induced by the three agents as seen by measurement of DNA content, annexin exposure and morphological characteristics. We also demonstrate that the process of apoptosis induced by butyrate and chemotherapeutic drugs involves the participation of caspases and induced activation of caspase-3, -8 and -9. Conclusions: We believe that butyrate could be a promising therapeutic agent for the treatment of leukemia in combination with other antineoplastic drugs.

Copyright © 2004 S. Karger AG, Basel


Author Contacts

Jacqueline Alvarez-Leite
Departamento de Bioquímica e Imunologia - ICB/UFMG
Caixa Postal 486
CEP 30 161 970 Belo Horizonte, MG (Brazil)
Fax +55 313441 5963, email author of paper